Search

Varian Medical Systems, Inc., Sara Lee Corp. and State Farm Mutual Automobile Insurance co. are the three companies which Value Line Secition and Opinion have chosen as model portfolios.

Varian Medical Systems plans to boost their overseas revenues to 80 percent of their total and profits could pile up. This overseas potential is one reason to like the company's shares which are also cheap and has the potential to climb 25 percent with their expansion overseas.

The shares of Varian Medical Systems, Inc. have a below-average price appreciation potential over the 2011-2013 timeframe. The Palo Alto, California-based company manufactures integrated cancer care systems and X-ray tubes for diagnostic imaging applications.

The shares of Varian Medical Systems Inc. offer high capital appreciation potential over the 2011-2013 timeframe. The Palo Alto-based company is the surviving entity of Varian Associates.

The price appreciation potential of the shares of Varian Medical Systems Inc. for the years 2011-2013 is discussed. The Palo Alto, California-based company manufactures integrated cancer care systems and X-ray tubes.

The price appreciation potential of the shares of Varian Medical Systems Inc. for the years 2010-2012 is discussed. The Palo Alto, California-based company makes integrated cancer care systems and X-ray tubes for diagnostic imaging.

Analysts are expecting a 10% sales increase and 8% earnings increase when Varian Medical Systems announces their 2007 third quarter report. The projected increase in cancer cases have aided the company's stock to rise from 1990 to 2005 but competition have put pressure on the stock's price after 2005.

The article provides the price appreciation potential of the shares of Varian Medical Systems Inc. for the years 2010-2012. The company offers integrated cancer care systems and X-ray tubes for diagnostic imaging applications.

A comparative analysis of the company sales and financial details of Varian Medical from 1988 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Varian Medical is the owner of the dominant technology for non-invasive treatment of cancer. A comparative analysis of the sales earnings and the financial details from the year 1988-2003 are detailed. Different financial ratios according to the Value Line Publication are given.